Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sumitomo Pharma Co Ltd
XMUN:DPM
Sumitomo Pharma Co Ltd
XMUN:DPM
Price:
10.654
EUR
1.2%
Market Closed
Market Cap:
€16B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sumitomo Pharma Co Ltd
XMUN:DPM
|
JP |
|
S
|
Standard Chartered PLC
F:STD
|
UK |
|
T
|
Tongcheng Travel Holdings Ltd
SWB:TEM
|
CN |
|
Industria de Diseno Textil SA
F:IXD1
|
ES |
|
D
|
DigitalOcean Holdings Inc
XMUN:0SU
|
US |
Wall St Price Targets
DPM Price Forecast
Based on 8 analysts
Based on 8 analysts
+0% Upside
from
€10.654
today
Sumitomo Pharma Co Ltd (DPM)’s 12-month stock price forecast through October 2027 has a consensus target of €10.66, broadly in line with the current price. The forecast is based on price targets from 8 Wall Street analysts.
DPM Analyst Rating
No ratings yet
No ratings yet
Sumitomo Pharma Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPM's stock price target?
Price Target
10.66
EUR
10.66
EUR
According to Wall Street analysts, the average 1-year price target for DPM is 10.66 EUR with a low forecast of 8.558 EUR and a high forecast of 16.015 EUR.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-83%
-83%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -83%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-4%
-4%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is -4%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-14%
-14%
Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -14%.